title: Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.
authors.affiliation: Hematology Unit, University of Rochester Medical Center, NY.
authors.forename: J M
authors.initials: JM
authors.lastname: Rowe
authors.forename: J J
authors.initials: JJ
authors.lastname: Mazza
authors.forename: J D
authors.initials: JD
authors.lastname: Hines
authors.forename: P A
authors.initials: PA
authors.lastname: Cassileth
authors.forename: M M
authors.initials: MM
authors.lastname: Oken
authors.forename: J M
authors.initials: JM
authors.lastname: Bennett
authors.forename: J
authors.initials: J
authors.lastname: Andersen
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D008942:Mitoxantrone / Q000008:administration & dosage / Q000009:adverse effects; D015337:Multicenter Studies as Topic; D012074:Remission Induction; D015996:Survival Rate; D014481:United States / Q000453:epidemiology
chemical_list: D005047:Etoposide; D008942:Mitoxantrone